ArticleMalaria journal2026
Accuracy of Plasmodium falciparum genetic data for estimating parasite prevalence and malaria incidence in Uganda.
Article in Malaria journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
30 authors.
Funding
Abstract
backgroundGenetic metrics derived from Plasmodium falciparum infections offer a potential complement to conventional malaria surveillance by utilizing features of parasite diversity and relatedness to estimate transmission intensity. However, the performance of genetic metrics to predict epidemiologic metrics across a wide range of transmission settings remains understudied.
methodsDried blood spots from 3563 symptomatic malaria cases were collected from 26 sentinel health facilities across Uganda during two collections in 2023. Amplicon deep sequencing of 165 polyallelic microhaplotypes was performed using MAD
resultsMarked geographic heterogeneity in malaria burden was evident across sites; parasite prevalence ranged from 5.0 to 49.23% in Round 1, while incidence ranged from 91 to 1062 cases per 1000 person-years (PY) in Round 1 and 33 to 1667 cases per 1000 PY in Round 2. COI and eCOI had a strong positive association with parasite prevalence. The proportion of highly related infection pairs was negatively associated with both prevalence and incidence and was the genetic metric most consistently associated with incidence. Nested grouped cross-validation identified single-predictor models using COI or eCOI as optimal for estimating prevalence, yielding a pooled cross-validated correlation of r = 0.79. Models estimating incidence showed weaker performance, with models incorporating both diversity and relatedness metrics achieving a pooled correlation of r = 0.37.
conclusionsMicrohaplotype-based metrics of within-host diversity, particularly COI and eCOI, reliably reflected spatial variation in malaria prevalence across Uganda, while between-host relatedness provided complementary information and was the strongest predictor of incidence. These findings indicate that parasite genomic metrics derived from polyallelic microhaplotypes can capture broad differences in transmission intensity reflected by parasite prevalence, but may have more limited ability to predict incidence. Integration of genomic metrics with harmonized epidemiologic data and expanded sampling of asymptomatic infections will be important next steps to understand the potential utility of parasite genetic metrics for malaria surveillance and subnational stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.